Sonoma Pharmaceuticals (SNOA) Current Leases (2017 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Current Leases of $146000.0 in Q4 2025, up 65.91% quarter-over-quarter from $88000.0 in Q3 2025, and up 62.22% on a YoY basis from $90000.0 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Current Leases (2017 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Current Leases history runs 9 years deep, the most recent figure standing at $146000.0 for Q4 2025.
- In Q4 2025, Current Leases rose 62.22% year-over-year to $146000.0; the TTM figure through Dec 2025 stood at $146000.0 (up 62.22% YoY), while the FY2025 annual figure was $58000.0, down 70.71% from the prior year.
- Current Leases was $146000.0 for Q4 2025 at Sonoma Pharmaceuticals, up from $88000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $282000.0 in Q3 2022 to a low of $58000.0 in Q1 2025.
- Historically, Current Leases has averaged $195050.0 across 5 years, with a median of $224500.0 in 2022.
- The sharpest annual moves came in 2021 and 2025: Current Leases soared 85.19% in 2021, then tumbled 70.71% in 2025.
- A 5-year view of Current Leases shows it stood at $261000.0 in 2021, then advanced by 5.75% to $276000.0 in 2022, then slumped by 34.42% to $181000.0 in 2023, then slumped by 50.28% to $90000.0 in 2024, then soared by 62.22% to $146000.0 in 2025.
- The last three Current Leases figures came in at $146000.0 (Q4 2025), $88000.0 (Q3 2025), and $96000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 23.81 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 7.58 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 5.58 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | 146,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 146,000.00 |
| Sep 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 96,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 116,000.00 |
| Jun 30, 2024 | 155,000.00 |
| Mar 31, 2024 | 198,000.00 |
| Dec 31, 2023 | 181,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Jun 30, 2023 | 233,000.00 |
| Mar 31, 2023 | 256,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Jun 30, 2022 | 233,000.00 |
| Mar 31, 2022 | 250,000.00 |
| Dec 31, 2021 | 261,000.00 |
| Sep 30, 2021 | 276,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Mar 31, 2021 | 240,000.00 |